Advertisement

Index by author

December 01, 1995; Volume 23,Issue 12

A

  1. Abbott, F S

    1. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
      J D Gordon, K W Riggs, D W Rurak, E Kwan, C Hall and F S Abbott
      Drug Metabolism and Disposition December 1995, 23 (12) 1383-1389;

  2. Atta-Asafo-Adjei, E

    1. Selectivity of flavin-containing monooxygenase 5 for the (S)-sulfoxidation of short-chain aralkyl sulfides.
      M B Fisher, M P Lawton, E Atta-Asafo-Adjei, R M Philpot and A E Rettie
      Drug Metabolism and Disposition December 1995, 23 (12) 1431-1433;

  3. Augustijns, P F

    1. Transport and metabolism of delta sleep-inducing peptide in cultured human intestinal epithelial cell monolayers.
      P F Augustijns and R T Borchardt
      Drug Metabolism and Disposition December 1995, 23 (12) 1372-1378;

B

  1. Bader, A

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  2. Baron, J

    1. Enzyme- and sex-specific differences in the intralobular localizations and distributions of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) and alcohol (hydroxysteroid) sulfotransferase a in rat liver.
      G Chen, J Baron and M W Duffel
      Drug Metabolism and Disposition December 1995, 23 (12) 1346-1353;

  3. Bazin-Redureau, M

    1. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
      M Bazin-Redureau, P Gires, P Chapelle, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition December 1995, 23 (12) 1400-1406;

  4. Bellward, G D

    1. Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex.
      M Levine and G D Bellward
      Drug Metabolism and Disposition December 1995, 23 (12) 1407-1411;

  5. Borchardt, R T

    1. Transport and metabolism of delta sleep-inducing peptide in cultured human intestinal epithelial cell monolayers.
      P F Augustijns and R T Borchardt
      Drug Metabolism and Disposition December 1995, 23 (12) 1372-1378;

  6. Boudinot, F D

    1. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
      S C Mehta, F D Boudinot and D R Lu
      Drug Metabolism and Disposition December 1995, 23 (12) 1368-1371;

  7. Bull, R J

    1. Metabolism of bromodichloroacetate in B6C3F1 mice.
      G Xu, D K Stevens and R J Bull
      Drug Metabolism and Disposition December 1995, 23 (12) 1412-1416;

C

  1. Cerniglia, C E

    1. Biotransformation of amitriptyline by Cunninghamella elegans.
      D Zhang, F E Evans, J P Freeman, B Duhart and C E Cerniglia
      Drug Metabolism and Disposition December 1995, 23 (12) 1417-1425;

  2. Chapelle, P

    1. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
      M Bazin-Redureau, P Gires, P Chapelle, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition December 1995, 23 (12) 1400-1406;

  3. Chauret, N

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

  4. Chen, G

    1. Enzyme- and sex-specific differences in the intralobular localizations and distributions of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) and alcohol (hydroxysteroid) sulfotransferase a in rat liver.
      G Chen, J Baron and M W Duffel
      Drug Metabolism and Disposition December 1995, 23 (12) 1346-1353;

  5. Chen, G P

    1. Oxidation of aldehydes catalyzed by pig liver flavin-containing monooxygenase.
      G P Chen, L L Poulsen and D M Ziegler
      Drug Metabolism and Disposition December 1995, 23 (12) 1390-1393;

  6. Christians, U

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

D

  1. De Graeve, J

    1. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
      R Herber, B Hercelin, J Van Cantfort, J De Graeve, S Fournel-Gigleux, T Taguchi and J Magdalou
      Drug Metabolism and Disposition December 1995, 23 (12) 1305-1314;

  2. De Leon, J H

    1. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
      J H De Leon, K J Martell, K P Vatsis and W W Weber
      Drug Metabolism and Disposition December 1995, 23 (12) 1354-1361;

  3. Dolan, M E

    1. Pharmacokinetics of O6-benzylguanine in rats and its metabolism by rat liver microsomes.
      S K Roy, E Gupta and M E Dolan
      Drug Metabolism and Disposition December 1995, 23 (12) 1394-1399;

  4. Dralle, H

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  5. Dubé, D

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

  6. Duffel, M W

    1. Enzyme- and sex-specific differences in the intralobular localizations and distributions of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) and alcohol (hydroxysteroid) sulfotransferase a in rat liver.
      G Chen, J Baron and M W Duffel
      Drug Metabolism and Disposition December 1995, 23 (12) 1346-1353;

  7. Duhart, B

    1. Biotransformation of amitriptyline by Cunninghamella elegans.
      D Zhang, F E Evans, J P Freeman, B Duhart and C E Cerniglia
      Drug Metabolism and Disposition December 1995, 23 (12) 1417-1425;

E

  1. Evans, F E

    1. Biotransformation of amitriptyline by Cunninghamella elegans.
      D Zhang, F E Evans, J P Freeman, B Duhart and C E Cerniglia
      Drug Metabolism and Disposition December 1995, 23 (12) 1417-1425;

F

  1. Fasco, M J

    1. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.
      Z Zhang, M J Fasco, Z Huang, F P Guengerich and L S Kaminsky
      Drug Metabolism and Disposition December 1995, 23 (12) 1339-1346;

  2. Fisher, M B

    1. Selectivity of flavin-containing monooxygenase 5 for the (S)-sulfoxidation of short-chain aralkyl sulfides.
      M B Fisher, M P Lawton, E Atta-Asafo-Adjei, R M Philpot and A E Rettie
      Drug Metabolism and Disposition December 1995, 23 (12) 1431-1433;

  3. Fortin, R

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

  4. Fournel-Gigleux, S

    1. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
      R Herber, B Hercelin, J Van Cantfort, J De Graeve, S Fournel-Gigleux, T Taguchi and J Magdalou
      Drug Metabolism and Disposition December 1995, 23 (12) 1305-1314;

  5. Franklin, M R

    1. Enhanced rates of cytochrome P450 metabolic-intermediate complex formation from nonmacrolide amines in rifampicin-treated rabbit liver microsomes.
      M R Franklin
      Drug Metabolism and Disposition December 1995, 23 (12) 1379-1382;

  6. Freeman, J P

    1. Biotransformation of amitriptyline by Cunninghamella elegans.
      D Zhang, F E Evans, J P Freeman, B Duhart and C E Cerniglia
      Drug Metabolism and Disposition December 1995, 23 (12) 1417-1425;

  7. Friesen, R

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

G

  1. Garton, K J

    1. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
      K J Garton, P Yuen, J Meinwald, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition December 1995, 23 (12) 1426-1430;

  2. Girard, Y

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

  3. Gires, P

    1. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
      M Bazin-Redureau, P Gires, P Chapelle, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition December 1995, 23 (12) 1400-1406;

  4. Gonschior, A K

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  5. Gordon, J D

    1. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
      J D Gordon, K W Riggs, D W Rurak, E Kwan, C Hall and F S Abbott
      Drug Metabolism and Disposition December 1995, 23 (12) 1383-1389;

  6. Guengerich, F P

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;
    2. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.
      Z Zhang, M J Fasco, Z Huang, F P Guengerich and L S Kaminsky
      Drug Metabolism and Disposition December 1995, 23 (12) 1339-1346;

  7. Gupta, E

    1. Pharmacokinetics of O6-benzylguanine in rats and its metabolism by rat liver microsomes.
      S K Roy, E Gupta and M E Dolan
      Drug Metabolism and Disposition December 1995, 23 (12) 1394-1399;

H

  1. Hackbarth, I

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  2. Hall, C

    1. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
      J D Gordon, K W Riggs, D W Rurak, E Kwan, C Hall and F S Abbott
      Drug Metabolism and Disposition December 1995, 23 (12) 1383-1389;

  3. Halpert, J R

    1. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
      P A Klekotka and J R Halpert
      Drug Metabolism and Disposition December 1995, 23 (12) 1434-1435;

  4. Hashmi, M

    1. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
      M Hashmi and S F Rosebrough
      Drug Metabolism and Disposition December 1995, 23 (12) 1362-1367;

  5. Herber, R

    1. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
      R Herber, B Hercelin, J Van Cantfort, J De Graeve, S Fournel-Gigleux, T Taguchi and J Magdalou
      Drug Metabolism and Disposition December 1995, 23 (12) 1305-1314;

  6. Hercelin, B

    1. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
      R Herber, B Hercelin, J Van Cantfort, J De Graeve, S Fournel-Gigleux, T Taguchi and J Magdalou
      Drug Metabolism and Disposition December 1995, 23 (12) 1305-1314;

  7. Huang, Z

    1. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.
      Z Zhang, M J Fasco, Z Huang, F P Guengerich and L S Kaminsky
      Drug Metabolism and Disposition December 1995, 23 (12) 1339-1346;

J

  1. Jarvi, E J

    1. Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity.
      X Wei, C M Loi, E J Jarvi and R E Vestal
      Drug Metabolism and Disposition December 1995, 23 (12) 1335-1338;

K

  1. Kaminsky, L S

    1. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.
      Z Zhang, M J Fasco, Z Huang, F P Guengerich and L S Kaminsky
      Drug Metabolism and Disposition December 1995, 23 (12) 1339-1346;

  2. Kharasch, E D

    1. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
      K J Garton, P Yuen, J Meinwald, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition December 1995, 23 (12) 1426-1430;

  3. Klekotka, P A

    1. Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11).
      P A Klekotka and J R Halpert
      Drug Metabolism and Disposition December 1995, 23 (12) 1434-1435;

  4. Kolars, J C

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  5. Kwan, E

    1. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
      J D Gordon, K W Riggs, D W Rurak, E Kwan, C Hall and F S Abbott
      Drug Metabolism and Disposition December 1995, 23 (12) 1383-1389;

L

  1. Lampen, A

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  2. Lawton, M P

    1. Selectivity of flavin-containing monooxygenase 5 for the (S)-sulfoxidation of short-chain aralkyl sulfides.
      M B Fisher, M P Lawton, E Atta-Asafo-Adjei, R M Philpot and A E Rettie
      Drug Metabolism and Disposition December 1995, 23 (12) 1431-1433;

  3. Levine, M

    1. Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex.
      M Levine and G D Bellward
      Drug Metabolism and Disposition December 1995, 23 (12) 1407-1411;

  4. Li, C

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

  5. Loi, C M

    1. Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity.
      X Wei, C M Loi, E J Jarvi and R E Vestal
      Drug Metabolism and Disposition December 1995, 23 (12) 1335-1338;

  6. Lu, D R

    1. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
      S C Mehta, F D Boudinot and D R Lu
      Drug Metabolism and Disposition December 1995, 23 (12) 1368-1371;

M

  1. Magdalou, J

    1. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
      R Herber, B Hercelin, J Van Cantfort, J De Graeve, S Fournel-Gigleux, T Taguchi and J Magdalou
      Drug Metabolism and Disposition December 1995, 23 (12) 1305-1314;

  2. Martell, K J

    1. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
      J H De Leon, K J Martell, K P Vatsis and W W Weber
      Drug Metabolism and Disposition December 1995, 23 (12) 1354-1361;

  3. Martinet, M

    1. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
      M Bazin-Redureau, P Gires, P Chapelle, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition December 1995, 23 (12) 1400-1406;

  4. Mehta, S C

    1. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
      S C Mehta, F D Boudinot and D R Lu
      Drug Metabolism and Disposition December 1995, 23 (12) 1368-1371;

  5. Meinwald, J

    1. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
      K J Garton, P Yuen, J Meinwald, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition December 1995, 23 (12) 1426-1430;

N

  1. Nicoll-Griffith, D

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

P

  1. Philpot, R M

    1. Selectivity of flavin-containing monooxygenase 5 for the (S)-sulfoxidation of short-chain aralkyl sulfides.
      M B Fisher, M P Lawton, E Atta-Asafo-Adjei, R M Philpot and A E Rettie
      Drug Metabolism and Disposition December 1995, 23 (12) 1431-1433;

  2. Poulsen, L L

    1. Oxidation of aldehydes catalyzed by pig liver flavin-containing monooxygenase.
      G P Chen, L L Poulsen and D M Ziegler
      Drug Metabolism and Disposition December 1995, 23 (12) 1390-1393;

R

  1. Rettie, A E

    1. Selectivity of flavin-containing monooxygenase 5 for the (S)-sulfoxidation of short-chain aralkyl sulfides.
      M B Fisher, M P Lawton, E Atta-Asafo-Adjei, R M Philpot and A E Rettie
      Drug Metabolism and Disposition December 1995, 23 (12) 1431-1433;

  2. Riggs, K W

    1. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
      J D Gordon, K W Riggs, D W Rurak, E Kwan, C Hall and F S Abbott
      Drug Metabolism and Disposition December 1995, 23 (12) 1383-1389;

  3. Rosebrough, S F

    1. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
      M Hashmi and S F Rosebrough
      Drug Metabolism and Disposition December 1995, 23 (12) 1362-1367;

  4. Roy, S K

    1. Pharmacokinetics of O6-benzylguanine in rats and its metabolism by rat liver microsomes.
      S K Roy, E Gupta and M E Dolan
      Drug Metabolism and Disposition December 1995, 23 (12) 1394-1399;

  5. Rurak, D W

    1. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
      J D Gordon, K W Riggs, D W Rurak, E Kwan, C Hall and F S Abbott
      Drug Metabolism and Disposition December 1995, 23 (12) 1383-1389;

S

  1. Scherrmann, J M

    1. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
      M Bazin-Redureau, P Gires, P Chapelle, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition December 1995, 23 (12) 1400-1406;

  2. Sewing, K F

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  3. Stevens, D K

    1. Metabolism of bromodichloroacetate in B6C3F1 mice.
      G Xu, D K Stevens and R J Bull
      Drug Metabolism and Disposition December 1995, 23 (12) 1412-1416;

T

  1. Taguchi, T

    1. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
      R Herber, B Hercelin, J Van Cantfort, J De Graeve, S Fournel-Gigleux, T Taguchi and J Magdalou
      Drug Metabolism and Disposition December 1995, 23 (12) 1305-1314;

  2. Thummel, K E

    1. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
      K J Garton, P Yuen, J Meinwald, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition December 1995, 23 (12) 1426-1430;

  3. Trimble, L

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

V

  1. Van Cantfort, J

    1. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
      R Herber, B Hercelin, J Van Cantfort, J De Graeve, S Fournel-Gigleux, T Taguchi and J Magdalou
      Drug Metabolism and Disposition December 1995, 23 (12) 1305-1314;

  2. Vatsis, K P

    1. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
      J H De Leon, K J Martell, K P Vatsis and W W Weber
      Drug Metabolism and Disposition December 1995, 23 (12) 1354-1361;

  3. Vestal, R E

    1. Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity.
      X Wei, C M Loi, E J Jarvi and R E Vestal
      Drug Metabolism and Disposition December 1995, 23 (12) 1335-1338;

W

  1. Watkins, P B

    1. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
      A Lampen, U Christians, F P Guengerich, P B Watkins, J C Kolars, A Bader, A K Gonschior, H Dralle, I Hackbarth and K F Sewing
      Drug Metabolism and Disposition December 1995, 23 (12) 1315-1324;

  2. Weber, W W

    1. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
      J H De Leon, K J Martell, K P Vatsis and W W Weber
      Drug Metabolism and Disposition December 1995, 23 (12) 1354-1361;

  3. Wei, X

    1. Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity.
      X Wei, C M Loi, E J Jarvi and R E Vestal
      Drug Metabolism and Disposition December 1995, 23 (12) 1335-1338;

X

  1. Xu, G

    1. Metabolism of bromodichloroacetate in B6C3F1 mice.
      G Xu, D K Stevens and R J Bull
      Drug Metabolism and Disposition December 1995, 23 (12) 1412-1416;

Y

  1. Yergey, J

    1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
      N Chauret, D Nicoll-Griffith, R Friesen, C Li, L Trimble, D Dubé, R Fortin, Y Girard and J Yergey
      Drug Metabolism and Disposition December 1995, 23 (12) 1325-1334;

  2. Yuen, P

    1. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
      K J Garton, P Yuen, J Meinwald, K E Thummel and E D Kharasch
      Drug Metabolism and Disposition December 1995, 23 (12) 1426-1430;

Z

  1. Zhang, D

    1. Biotransformation of amitriptyline by Cunninghamella elegans.
      D Zhang, F E Evans, J P Freeman, B Duhart and C E Cerniglia
      Drug Metabolism and Disposition December 1995, 23 (12) 1417-1425;

  2. Zhang, Z

    1. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.
      Z Zhang, M J Fasco, Z Huang, F P Guengerich and L S Kaminsky
      Drug Metabolism and Disposition December 1995, 23 (12) 1339-1346;

  3. Ziegler, D M

    1. Oxidation of aldehydes catalyzed by pig liver flavin-containing monooxygenase.
      G P Chen, L L Poulsen and D M Ziegler
      Drug Metabolism and Disposition December 1995, 23 (12) 1390-1393;
Back to top

In this issue